CNS Pharmaceuticals, Inc. CNSP
4.93
(0.22)
(4.27%)
as of 25 Sep
- Market cap
- $7.5M
- P/E
- 0.0×
Follow CNSP
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
5.86 | 0.89 | 1.98 | 5.81 |
+8 more quarters Free account |
Net Debt/EBITDA |
7.43 | 0.59 | 1.20 | 3.03 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.37 | 0.94 | 0.51 | 0.68 | |
Capex/Depreciation |
(0.34) | (3.26) | (18.20) | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.52) | (6.89) | (6.93) | (3.89) | |
Cash per Share |
2.92 | 4.37 | 16.26 | 17.65 | |
Shareholders Equity per Share |
2.66 | 0.10 | 10.21 | 17.73 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.66 | 0.10 | 10.21 | 17.73 | |
Free Cash Flow |
(3.54) | (4.65) | (3.07) | (2.17) | |
Working Capital |
18.19 | (0.50) | 4.00 | 9.43 | |
Capital Expenditures |
0.00 | (0.01) | (0.02) | — | |
Net Current Asset Value |
18.19 | (0.50) | 4.00 | 9.43 | |
| Other line items | |||||
Quick Ratio |
5.35 | 0.64 | 1.76 | 5.04 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.52) | (6.88) | (6.89) | (3.89) | |
Capex per Share |
0.00 | (0.01) | (0.04) | 0.00 | |
Average Payables |
2.50 | 3.46 | 2.99 | 2.98 | |
Average Assets |
18.22 | 9.20 | 8.66 | 9.64 | |
Average Common Equity |
15.66 | 5.52 | 5.35 | 6.63 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | — | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates